Go All-In On Actavi...
Health Care: Drugs
Cytori Therapeutics Inc. (CYTX: NASDAQ)
$2.33 0.01 | 0.43%
06/18/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 25.72M | 36.92M | 52.67M | 12.85M |
| Receivables | 3.93M | 2.26M | 2.07M | 1.63M |
| Inventories | 3.18M | 3.32M | 3.38M | 2.59M |
| Other Current Assets | 1.16M | 837.00K | 834.00K | 1.02M |
| Total Current Assets | 33.98M | 43.34M | 58.95M | 18.10M |
| Property, Plant & Equipment, Gross | 10.78M | 9.70M | 9.30M | 8.25M |
| Accumulated Depreciation & Depletion | 8.61M | 7.99M | 7.61M | 6.94M |
| Property, Plant & Equipment, Net | 2.17M | 1.71M | 1.68M | 1.31M |
| Intangibles | 0.00 | 192.00K | 413.00K | 635.00K |
| Other Non-Current Assets | 3.18M | 2.37M | 1.38M | 780.00K |
| Total Non-Current Assets | 9.27M | 8.20M | 7.39M | 6.65M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 43.25M | 51.53M | 66.35M | 24.75M |
| Accounts Payable | 1.58M | 272.00K | 6.77M | 1.31M |
| Short Term Debt | 9.78M | 2.49M | 6.45M | 2.70M |
| Other Current Liabilities | 418.00K | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 17.61M | 7.82M | 13.22M | 8.18M |
| Long Term Debt | 12.90M | 21.96M | 0.00 | 2.79M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 6.28M | 11.80M | 17.00M | 17.43M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 19.18M | 33.77M | 30.25M | 20.22M |
| Total Liabilities | 36.80M | 41.59M | 43.47M | 28.41M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 6.46M | 9.95M | 22.87M | -3.66M |
| Common Par | 66.00K | 57.00K | 52.00K | 40.00K |
| Additional Paid In Capital | 281.12M | 252.34M | 232.82M | 178.81M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -274.73M | -242.45M | -210.00M | -182.50M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Capitalization | 19.36M | 31.91M | 22.87M | -868.00K |
| Total Equity | 6.46M | 9.95M | 22.87M | -3.66M |
| Total Liabilities & Stock Equity | 43.25M | 51.53M | 66.35M | 24.75M |
| Total Common Shares Outstanding | 65.91M | 56.59M | 51.96M | 40.04M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 58.68M | 53.50M | 45.95M | 35.94M |
| Diluted Weighted Shares Outstanding | 58.68M | 53.50M | 45.95M | 35.94M |
| Number of Employees | 127 | 128 | 124 | 93 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with CYTX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- UserMy SP portfolio
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor6 Drug Stocks Unworthy of B...
Latest CYTX Headlines from TheStreet
- 4 Health Care Stocks Under $10 to Watch 04.16.13 | 03:04 pm
- 5 Stocks Setting Up to Break Out 01.25.13 | 01:01 pm
- Stocks Socked Despite Upbeat China Numbers; Apple Falls 12.14.12 | 04:12 pm
- 5 Stocks Under $10 Set to Soar 10.11.12 | 01:10 pm
- 5 Biotech Stocks Under $10 Blasting Higher 08.14.12 | 03:08 pm
- 5 Biotech Stocks Under $5 Making Bullish Moves 06.21.12 | 01:06 pm
- 8 Stocks Under $10 Soaring Higher 05.10.12 | 01:05 pm
- Tuesday's Top 10 Articles, Videos on TheStreet 02.07.12 | 01:02 pm
- 6 Drug Stocks Unworthy of Biotech Bull Market 02.07.12 | 12:02 pm
- 8 Stocks Under $10 Ripping Higher 01.26.12 | 02:01 pm
Press Releases for CYTX
- Cytori Patents Method Of Treating Renal Diseases Using Adipose-Derived Regenerative Cells - Business Wire 03.28.13 | 08:03 am
- Cytori Provides Update In 510(k) Appeal Decision - Business Wire 03.22.13 | 02:03 pm
- Cytori Therapeutics To Present At The 25th Annual Roth Conference On March 18 - Business Wire 03.11.13 | 08:03 am
- Cytori Reports 2012 Business And Financial Results; Provides Outlook For 2013 - Business Wire 03.07.13 | 04:03 pm
- Cytori To Webcast Fourth Quarter And Year End Financial Results On March 7 - Business Wire 02.28.13 | 08:02 am
- Cytori Appoints Dr. Steven Kesten As Executive Vice President And Chief Medical Officer - Business Wire 02.26.13 | 08:02 am
- Intravase® Approval Opens Vascular Market For Cytori - Business Wire 02.25.13 | 09:02 am
- Cytori Announces Presentation At Biotech Showcase™ On January 8th - Business Wire 01.04.13 | 08:01 am
- Cytori Therapeutics Prices $20.0 Million Public Offering Of Common Stock - Business Wire 12.14.12 | 09:12 am
- Cytori Therapeutics Proposes Public Offering Of Common Stock - Business Wire 12.13.12 | 04:12 pm
Partner Headlines for CYTX
- With Cytori Therapeutics, The Waiting Is The Hardest Part - Seeking Alpha 08.14.12 | 09:08 am
- Cytori Is A Compelling Short Sale Opportunity - Seeking Alpha 03.19.12 | 09:03 am
- Earnings Report Card, Regenerative Medicine Universe Edition - Seeking Alpha 08.11.11 | 09:08 am
- Analyst Interview - International Stem Cell - Analyst Blog - Zacks 07.27.11 | 06:07 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 07.13.11 | 09:07 am
- Cytori Therapeutics: Sales Miss? Yes. Bad Quarter? No - Seeking Alpha 05.06.11 | 03:05 pm
- Some Hidden Gem Stocks That May Have High Returns! - AOL 04.05.11 | 07:04 pm
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- 9 Cheap Stocks Under $10 Making New Price Highs - Seeking Alpha 03.25.11 | 08:03 am
- Options Brief: Cytori Therapeutics (CYTX) - Benzinga 03.17.11 | 01:03 pm
